VolitionRx
Henderson, Nevada, United States · Biotechnology, Genetics, Health Care
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of dis
Key facts
- Headquarters
- Henderson, Nevada, United States
- Employees
- 86
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Public (VNRX)
- Website
- volitionrx.com
- Company page
Recent activity at VolitionRx
- : VOLITIONRX LTD
- : VolitionRx and Hologic Enter Co-Marketing Agreement for Nu.Q® Discover Services.
- : VOLITIONRX LTD
- : Volition Signs Automated Cancer Test Agreement with Fujifilm Vet Systems
- : VolitionRx Limited Launches High Throughput Synthetic Sepsis Method to Aid Therapeutic Development for NETs-Related Diseases.
- : VOLITIONRX LTD
- : VolitionRx Limited Appoints Dr Andrew Retter as Chief Medical Officer
- : Volitionrx Secures Approximately $5.5 Million In Belgium Regional Government Financing From Wallonie Entreprendre
- : VOLITIONRX LTD
VolitionRx funding history
| Date | Round | Amount |
|---|---|---|
| May 2025 | Venture | $16.3M |
| Mar 2024 | Pre-Seed | $100K |
| Dec 2023 | Funding Round | $5.5M |
| Aug 2018 | Venture | $24.0M |
Leadership
- Edward Futcher, Director
- Habib Skaff, Director
- Alan Colman, Director
- Guy Innes, Director
- Martin Faulkes, Director
- Cameron Reynolds, Executive Officer, Director
- PHILLIP BARNES, Director
- RODNEY ROOTSAERT, Executive Officer
Verified email and direct lines for VolitionRx’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
VolitionRx in the news
- Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Yahoo Finance (Aug 27, 2026)
- VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer - NAI500 (May 08, 2019)
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance (Aug 26, 2026)
- VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats - PR Newswire (May 06, 2026)
- VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - Yahoo Finance (Sep 14, 2026)
- VolitionRx (NYSEAM:VNRX) - Stock Analysis - Simply Wall St (Dec 02, 2017)
- VolitionRX (VNRX) Stock Price, News & Analysis - MarketBeat (Nov 17, 2017)
- VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update - Yahoo Finance (Aug 11, 2026)
Companies similar to VolitionRx
- Gaomei Gene · Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
- GenoME Diagnostics · Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
- Passage Bio · Biotechnology, Genetics, Health Care, Therapeutics
- Pathos AI · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Predicine · Biotechnology, Health Care, Health Diagnostics, Therapeutics
About VolitionRx: questions and answers
What does VolitionRx do?
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of dis
Where is VolitionRx headquartered?
VolitionRx is headquartered in Henderson, Nevada, United States.
How many employees does VolitionRx have?
VolitionRx has about 86 employees.
Has VolitionRx raised funding?
Yes. Fundz has recorded 4 funding events for VolitionRx. The most recent, $16.3M, was in May 2025.
What is the latest news on VolitionRx?
On Jan 28, 2026, VOLITIONRX LTD
Is VolitionRx a public company?
Yes. VolitionRx is publicly traded under the ticker VNRX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy